ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Clinical trials for ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot offers hope for easier lung cancer treatment
Disease control OngoingThis study is testing a new, easier-to-administer injection (a shot under the skin) for a lung cancer drug called amivantamab, which is given with another drug called lazertinib. It aims to see if this new method works as well as the standard intravenous (IV) infusion but takes l…
Matched conditions: ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for Tough-to-Treat lung cancer: experimental combo challenges standard care
Disease control OngoingThis study is for people with advanced non-small cell lung cancer that has continued to grow despite previous immunotherapy and chemotherapy. It compares a new two-drug combination (ceralasertib plus durvalumab) against the standard chemotherapy drug docetaxel. The main goal is t…
Matched conditions: ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC